| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0021-9150(87)90202-4 |
| P8608 | Fatcat ID | release_hhhf3hf65fbenkcpwadcade6dy |
| P698 | PubMed publication ID | 3426656 |
| P2093 | author name string | Mitchell D | |
| Williams RA | |||
| Paigen B | |||
| Morrow A | |||
| Holmes PA | |||
| P433 | issue | 3 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 231-240 | |
| P577 | publication date | 1987-12-01 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | Quantitative assessment of atherosclerotic lesions in mice | |
| P478 | volume | 68 |
| Q27322801 | 11β-hydroxysteroid dehydrogenase type 1 gene knockout attenuates atherosclerosis and in vivo foam cell formation in hyperlipidemic apoE⁻/⁻ mice |
| Q34049297 | 15-Deoxy-Δ¹²,¹⁴ prostaglandin J₂ reduces the formation of atherosclerotic lesions in apolipoprotein E knockout mice |
| Q37286111 | 17beta-estradiol prevents early-stage atherosclerosis in estrogen receptor-alpha deficient female mice |
| Q89340951 | 3D MicroCT spatial and temporal characterization of thoracic aorta perivascular adipose tissue and plaque volumes in the ApoE-/- mouse model |
| Q41012941 | 8-Hydroxy-2-deoxyguanosine prevents plaque formation and inhibits vascular smooth muscle cell activation through Rac1 inactivation |
| Q92540743 | A Critical Role of PCSK9 in Mediating IL-17-Producing T Cell Responses in Hyperlipidemia |
| Q85741672 | A VLP-based vaccine against interleukin-1α protects mice from atherosclerosis |
| Q28589301 | A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice |
| Q77926970 | A direct role for the macrophage low density lipoprotein receptor in atherosclerotic lesion formation |
| Q30423567 | A leukocyte-mimetic magnetic resonance imaging contrast agent homes rapidly to activated endothelium and tracks with atherosclerotic lesion macrophage content |
| Q36927177 | A new mouse mutant for the LDL receptor identified using ENU mutagenesis |
| Q45861575 | A novel endothelial cell-based gene therapy platform for the in vivo delivery of apolipoprotein E. |
| Q35754358 | A practical approach to using mice in atherosclerosis research. |
| Q91625806 | A preclinical ultrasound method for the assessment of vascular disease progression in murine models |
| Q59460160 | A procedure for obtaining whole mount mouse aortas that allows atherosclerotic lesions to be quantified |
| Q39868162 | A reconstituted HDL containing V156K or R173C apoA-I exhibited anti-inflammatory activity in apo-E deficient mice and showed resistance to myeloperoxidase-mediated oxidation |
| Q27347208 | A volumetric method for quantifying atherosclerosis in mice by using microCT: comparison to en face |
| Q38310381 | ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis |
| Q77340592 | Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice |
| Q37364649 | Absence of P-selectin delays fatty streak formation in mice |
| Q77231603 | Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice |
| Q33808556 | Absence of myeloid COX-2 attenuates acute inflammation but does not influence development of atherosclerosis in apolipoprotein E null mice |
| Q36606722 | Absence of regulated splicing of fibronectin EDA exon reduces atherosclerosis in mice. |
| Q35833075 | Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A. |
| Q42559366 | Accelerating the pace of atherosclerosis research |
| Q40362496 | Addition of aspirin to a fish oil-rich diet decreases inflammation and atherosclerosis in ApoE-null mice |
| Q33226674 | Adhesion of T and B lymphocytes to mouse atherosclerotic aortas: association with lesion topology and VCAM-1 expression |
| Q35286806 | Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice |
| Q33635141 | Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia |
| Q36543639 | Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice |
| Q40716232 | Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice. |
| Q36377589 | Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice |
| Q35287418 | Antagonism of the antithrombotic and anti-atherosclerotic actions of aspirin by rofecoxib in the cholesterol-fed rabbit |
| Q34594762 | Anti-P. gingivalis response correlates with atherosclerosis |
| Q89219283 | Anti-TIM-1 Monoclonal Antibody (RMT1-10) Attenuates Atherosclerosis By Expanding IgM-producing B1a Cells |
| Q44502396 | Anti-atherogenic effect of soya and rice-protein isolate, compared with casein, in apolipoprotein E-deficient mice |
| Q34505767 | Anti-heat shock protein 70 autoantibody epitope changes and BD091 promotes atherosclerosis in rats |
| Q46231561 | Antiatherosclerotic effect of farnesoid X receptor |
| Q46160486 | Antibodies against electronegative LDL inhibit atherosclerosis in LDLr-/- mice. |
| Q46165765 | Antiphospholipid antibodies from a patient with primary antiphospholipid syndrome enhance experimental atherosclerosis |
| Q24657323 | Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis |
| Q30322098 | Apo E structure determines VLDL clearance and atherosclerosis risk in mice. |
| Q34355358 | Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes |
| Q35763533 | Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors |
| Q24299006 | Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis |
| Q23909545 | Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets |
| Q35843366 | Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease. |
| Q28212769 | Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime |
| Q46953909 | Atherogenesis in transgenic mice expressing human apolipoprotein(a) |
| Q34349328 | Atherogenic diets exacerbate colitis in mice deficient in glutathione peroxidase. |
| Q49167870 | Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic mice |
| Q41074472 | Atherosclerosis and plasma and liver lipids in nine inbred strains of mice |
| Q42871419 | Atherosclerosis induced by a high-fat diet is alleviated by lithium chloride via reduction of VCAM expression in ApoE-deficient mice |
| Q47855094 | Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice |
| Q30416293 | Atherosclerosis susceptibility Loci identified in an extremely atherosclerosis-resistant mouse strain |
| Q36028330 | Atherosclerosis: humoral and cellular factors of inflammation |
| Q46847348 | Atherosclerotic plaque imaging using phase-contrast X-ray computed tomography. |
| Q33976585 | Autoimmunity in atherosclerosis. The role of autoantigens |
| Q41766763 | Baicalin and geniposide inhibit the development of atherosclerosis by increasing Wnt1 and inhibiting dickkopf-related protein-1 expression |
| Q46102690 | Betaine supplementation attenuates atherosclerotic lesion in apolipoprotein E-deficient mice |
| Q40164897 | Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice |
| Q36445238 | Bmper inhibits endothelial expression of inflammatory adhesion molecules and protects against atherosclerosis. |
| Q41147790 | Bone marrow-specific caspase-1/11 deficiency inhibits atherosclerosis development in Ldlr(-/-) mice |
| Q37364510 | BubR1 Insufficiency Results in Decreased Macrophage Proliferation and Attenuated Atherogenesis in Apolipoprotein E-Deficient Mice |
| Q37294671 | C-peptide promotes lesion development in a mouse model of arteriosclerosis |
| Q74106071 | C3H apoE(-/-) mice have less atherosclerosis than C57BL apoE(-/-) mice despite having a more atherogenic serum lipid profile |
| Q51570758 | C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. |
| Q30891436 | CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice |
| Q34238768 | Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null mice |
| Q51463179 | Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice. |
| Q42484040 | Carboxyl ester lipase expression in macrophages increases cholesteryl ester accumulation and promotes atherosclerosis. |
| Q46918588 | Cell adhesion molecules and eNOS expression in aorta of normocholesterolemic mice with different predispositions to atherosclerosis |
| Q74439056 | Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice |
| Q52879060 | Changes in arterial function in a mouse model of human familial hypercholesterolaemia. |
| Q30425082 | Characterization of Ath29, a major mouse atherosclerosis susceptibility locus, and identification of Rcn2 as a novel regulator of cytokine expression |
| Q46960347 | Characterization of a new mouse model for human apolipoprotein A-I/C-III/A-IV deficiency |
| Q55038629 | Chlamydia pneumoniae Infection Exacerbates Atherosclerosis in ApoB100only/LDLR-/- Mouse Strain. |
| Q34130686 | Chlamydia pneumoniae and hyperlipidemia are co-risk factors for atherosclerosis: infection prior to induction of hyperlipidemia does not accelerate development of atherosclerotic lesions in C57BL/6J mice |
| Q28362988 | Chlamydia pneumoniae exacerbates aortic inflammatory foci caused by murine cytomegalovirus infection in normocholesterolemic mice |
| Q37873686 | Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice |
| Q37383956 | Cholesterol lowering in low density lipoprotein receptor knockout mice overexpressing apolipoprotein E. |
| Q44272158 | Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice |
| Q38790867 | Cholic Acid Enhances Visceral Adiposity, Atherosclerosis and Nonalcoholic Fatty Liver Disease in Microminipigs |
| Q35796500 | Chronic alcohol feeding inhibits atherogenesis in C57BL/6 hyperlipidemic mice. |
| Q36330538 | Chronic intermittent hypoxia induces atherosclerosis |
| Q33916483 | Chronic oral infection with Porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile |
| Q39113883 | Cloning and expression of an anti-LDL(-) single-chain variable fragment, and its inhibitory effect on experimental atherosclerosis |
| Q36114199 | Combined B, T and NK Cell Deficiency Accelerates Atherosclerosis in BALB/c Mice |
| Q33635135 | Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. |
| Q34075624 | Combined vitamin C and vitamin E deficiency worsens early atherosclerosis in apolipoprotein E-deficient mice |
| Q35570422 | Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice |
| Q37255764 | Conjugated linoleic acid and atherosclerosis: studies in animal models. |
| Q50187702 | Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies-Statement From ATVB Council. |
| Q40243205 | Correlation between Mitochondrial Reactive Oxygen and Severity of Atherosclerosis |
| Q37609624 | Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis |
| Q47103922 | DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice |
| Q97525815 | Deciphering Macrophage Phenotypes upon Lipid Uptake and Atherosclerosis |
| Q35765195 | Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene |
| Q37412379 | Deficiency of adipose differentiation-related protein impairs foam cell formation and protects against atherosclerosis |
| Q91651357 | Deletion of the Mir-106b~ 25 MicroRNA cluster attenuates atherosclerosis in Apolipoprotein E knockout mice |
| Q37889038 | Diet and atherosclerosis in apolipoprotein E-deficient mice |
| Q34137756 | Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice |
| Q44594273 | Dietary Cholate Is Required for Antiatherogenic Effects of Ethanol in Mouse Models |
| Q44356338 | Dietary cholesterol reduces lipoprotein lipase activity in the atherosclerosis-susceptible Bio F(1)B hamster |
| Q44152599 | Dietary cholesterol-oxidation products accumulate in serum and liver in apolipoprotein E-deficient mice, but do not accelerate atherosclerosis |
| Q78091434 | Dietary conjugated linoleic acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis model |
| Q45979644 | Dietary pine bark extract reduces atherosclerotic lesion development in male ApoE-deficient mice by lowering the serum cholesterol level. |
| Q44300091 | Dietary sodium chloride restriction enhances aortic wall lipid storage and raises plasma lipid concentration in LDL receptor knockout mice. |
| Q43687624 | Dietary vegetable oil and wood derived plant stanol esters reduce atherosclerotic lesion size and severity in apoE*3-Leiden transgenic mice. |
| Q36584577 | Differences in health status affect susceptibility and mapping of genetic loci for atherosclerosis (fatty streak) in inbred mice |
| Q37402144 | Different responsiveness to a high-fat/cholesterol diet in two inbred mice and underlying genetic factors: a whole genome microarray analysis |
| Q40427348 | Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma |
| Q35243465 | Differential requirement for nitric oxide in IGF-1-induced anti-apoptotic, anti-oxidant and anti-atherosclerotic effects |
| Q58080066 | Dioxin-like PCB 126 increases intestinal inflammation and disrupts gut microbiota and metabolic homeostasis |
| Q47684833 | Dioxin-like PCB 126 increases systemic inflammation and accelerates atherosclerosis in lean LDL receptor deficient mice. |
| Q34271205 | Disturbed flow enhances inflammatory signaling and atherogenesis by increasing thioredoxin-1 level in endothelial cell nuclei |
| Q42134468 | Dynamic immune cell accumulation during flow-induced atherogenesis in mouse carotid artery: an expanded flow cytometry method |
| Q58227619 | Effect of Lactobacillus delbrueckii on cholesterol metabolism in germ-free mice and on atherogenesis in apolipoprotein E knock-out mice |
| Q30441825 | Effect of aging on fatty streak formation in a diet-induced mouse model of atherosclerosis |
| Q63385894 | Effect of echium oil combined with phytosterols on biomarkers of atherosclerosis in LDLr-knockout mice: Echium oil is a potential alternative to marine oils for use in functional foods |
| Q42537447 | Effect of probucol on serum lipids, atherosclerosis and toxicology in fat-fed LDL receptor deficient mice |
| Q35546179 | Effects of FXR in foam-cell formation and atherosclerosis development |
| Q44454571 | Effects of MF-tricyclic, a selective cyclooxygenase-2 inhibitor, on atherosclerosis progression and susceptibility to cytomegalovirus replication in apolipoprotein-E knockout mice |
| Q36102796 | Effects of isoflurane on coronary blood flow velocity in young, old and ApoE(-/-) mice measured by Doppler ultrasound |
| Q34033240 | Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice |
| Q72996209 | Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice |
| Q44474830 | Effects of vitamin supplementation and hyperhomocysteinemia on atherosclerosis in apoE-deficient mice |
| Q54389170 | Elastin-derived peptides potentiate atherosclerosis through the immune Neu1-PI3Kγ pathway. |
| Q37250797 | Endoplasmic reticulum factor ERLIN2 regulates cytosolic lipid content in cancer cells |
| Q35870151 | Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice |
| Q45790640 | Endothelial MHC class II antigen expression and endarteritis associated with Marek's disease virus infection in chickens |
| Q35636955 | Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging. |
| Q46976978 | Endothelial expression of endoglin in normocholesterolemic and hypercholesterolemic C57BL/6J mice before and after atorvastatin treatment. |
| Q45013809 | Endothelial lipase modulates susceptibility to atherosclerosis in apolipoprotein-E-deficient mice |
| Q35740707 | Enhanced ABCG1 expression increases atherosclerosis in LDLr-KO mice on a western diet |
| Q28268889 | Enhanced atheroprotection and lesion remodelling by targeting the foam cell and increasing plasma cholesterol acceptors |
| Q46167412 | Estrogen modulates the mechanical homeostasis of mouse arterial vessels through nitric oxide |
| Q37322112 | Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice |
| Q34361591 | Evaluation of foam cell formation in cultured macrophages: an improved method with Oil Red O staining and DiI-oxLDL uptake |
| Q84704187 | Evaluation of mild hyperhomocysteinemia during the development of atherosclerosis in apolipoprotein E-deficient and normal mice |
| Q43691660 | Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice reduces atherogenesis in response to a high fat-high cholesterol diet. |
| Q45277549 | Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis |
| Q37379082 | Fibrinogen deficiency is compatible with the development of atherosclerosis in mice |
| Q36527433 | Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice |
| Q74292655 | Fibrinogen in rat gastrointestinal lymph before, during and after intraduodenal administration of emulsified triglyceride: fibrinogen bound to chylomicrons in gastrointestinal lymph is functional |
| Q78554580 | Fibrinogen-coated chylomicrons in gastrointestinal lymph: a new rationale regarding the arterial deposition of postprandial lipids |
| Q34657083 | Food restriction by intermittent fasting induces diabetes and obesity and aggravates spontaneous atherosclerosis development in hypercholesterolaemic mice. |
| Q43704009 | Freunds adjuvant alone is antiatherogenic in apoE-deficient mice and specific immunization against TNFalpha confers no additional benefit |
| Q36663052 | G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity. |
| Q34785574 | Gene Deficiency in Activating Fcγ Receptors Influences the Macrophage Phenotypic Balance and Reduces Atherosclerosis in Mice. |
| Q30421525 | Genetic analysis of atherosclerosis and glucose homeostasis in an intercross between C57BL/6 and BALB/cJ apolipoprotein E-deficient mice |
| Q34229709 | Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice |
| Q40559434 | Genetic models of human vascular disease |
| Q47132750 | Global inactivation of carboxylesterase 1 (Ces1/Ces1g) protects against atherosclerosis in Ldlr -/- mice. |
| Q50481371 | Green tea epigallocatechin-3-gallate attenuates Porphyromonas gingivalis-induced atherosclerosis. |
| Q28388331 | Hearts from mice fed a non-obesogenic high-fat diet exhibit changes in their oxidative state, calcium and mitochondria in parallel with increased susceptibility to reperfusion injury |
| Q44814610 | Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice |
| Q51779135 | Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited. |
| Q34609585 | Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis |
| Q35169009 | Hepatic lipase expression in macrophages contributes to atherosclerosis in apoE-deficient and LCAT-transgenic mice |
| Q40859344 | High density lipoproteins and coronary heart disease. Future prospects in gene therapy |
| Q73486403 | High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithinchoesteryl acyltransferase |
| Q51578321 | High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils. |
| Q38816765 | High-methionine diets accelerate atherosclerosis by HHcy-mediated FABP4 gene demethylation pathway via DNMT1 in ApoE(-/-) mice |
| Q91304776 | Homocysteine accelerates atherosclerosis by inhibiting scavenger receptor class B member1 via DNMT3b/SP1 pathway |
| Q36812669 | Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms. |
| Q35800759 | Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse |
| Q44474819 | Hypercholesterolemia in pregnant mice does not affect atherosclerosis in adult offspring |
| Q33757710 | Hyperhomocysteinemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J mice |
| Q47788311 | Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis |
| Q28482520 | Hyperlipidemia and atherosclerotic lesion development in Ldlr-deficient mice on a long-term high-fat diet |
| Q83639687 | Hypertension resulting from overexpression of translationally controlled tumor protein increases the severity of atherosclerosis in apolipoprotein E knock-out mice |
| Q37368296 | IFN-gamma potentiates atherosclerosis in ApoE knock-out mice |
| Q64999429 | IRE1α prevents hepatic steatosis by processing and promoting the degradation of select microRNAs. |
| Q34021005 | Identifying novel genes for atherosclerosis through mouse-human comparative genetics |
| Q33338017 | Imaging aspects of cardiovascular disease at the cell and molecular level |
| Q31132267 | Impact of glutathione peroxidase-1 deficiency on macrophage foam cell formation and proliferation: implications for atherogenesis |
| Q34168259 | Impact of macrophage inflammatory protein-1α deficiency on atherosclerotic lesion formation, hepatic steatosis, and adipose tissue expansion |
| Q37523493 | Impact of the Consumption of Tea Polyphenols on Early Atherosclerotic Lesion Formation and Intestinal Bifidobacteria in High-Fat-Fed ApoE-/- Mice |
| Q37498720 | Impaired cholesterol metabolism and enhanced atherosclerosis in clock mutant mice |
| Q74144043 | Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation |
| Q58842332 | In focus in HCB |
| Q94572191 | In vivo data: treatment with the F11R/JAM-A peptide 4D decreases mortality and reduces the generation of atherosclerotic plaques in ApoE-deficient mice |
| Q28346527 | Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages |
| Q36143345 | Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages |
| Q37353969 | Increased atherosclerosis in streptozotocin-induced diabetic mice |
| Q44174326 | Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein |
| Q33822096 | Incremental replacement of saturated fats by n-3 fatty acids in high-fat, high-cholesterol diets reduces elevated plasma lipid levels and arterial lipoprotein lipase, macrophages and atherosclerosis in LDLR-/- mice |
| Q40882983 | Infection with Toxoplasma gondii increases atherosclerotic lesion in ApoE-deficient mice. |
| Q35603368 | Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology |
| Q28385653 | Inhaled asbestos exacerbates atherosclerosis in apolipoprotein E-deficient mice via CD4+ T cells |
| Q35839549 | Inherent and benzo[a]pyrene-induced differential aryl hydrocarbon receptor signaling greatly affects life span, atherosclerosis, cardiac gene expression, and body and heart growth in mice |
| Q35782654 | Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice |
| Q73832432 | Inhibition of cytokine-induced vascular cell adhesion molecule-1 expression; possible mechanism for anti-atherogenic effect of Agastache rugosa |
| Q41164669 | Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. |
| Q44480855 | Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE-/- mice by SC-435. |
| Q43880307 | Inhibition of the renin-angiotensin system ameliorates genetically determined hyperinsulinemia |
| Q52544667 | Insulin-like growth factor II plays a central role in atherosclerosis in a mouse model. |
| Q73409234 | Interleukin (IL)-4 deficiency does not influence fatty streak formation in C57BL/6 mice |
| Q43293010 | Intervention with fish oil, but not with docosahexaenoic acid, results in lower levels of hepatic soluble epoxide hydrolase with time in apoE knockout mice. |
| Q40659567 | Involvement of ICAM-1 in the progression of atherosclerosis in APOE-knockout mice |
| Q33908213 | Involvement of the tyrosinase gene in the deposition of cardiac lipofuscin in mice. Association with aortic fatty streak development |
| Q34470216 | Is there a genetic basis for resistance to atherosclerosis? |
| Q50219604 | Isolation and Characterization of Aortic Dendritic Cells and Lymphocytes in Atherosclerosis |
| Q21144449 | LRP1 functions as an atheroprotective integrator of TGFbeta and PDFG signals in the vascular wall: implications for Marfan syndrome |
| Q91714717 | Label-free photoacoustic and ultrasound imaging for murine atherosclerosis characterization |
| Q33642949 | Lack of P2Y13 in mice fed a high cholesterol diet results in decreased hepatic cholesterol content, biliary lipid secretion and reverse cholesterol transport |
| Q28198287 | Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis |
| Q46968906 | Lack of the antioxidant glutathione peroxidase-1 does not increase atherosclerosis in C57BL/J6 mice fed a high-fat diet. |
| Q42532089 | Lack of tyrosylprotein sulfotransferase activity in hematopoietic cells drastically attenuates atherosclerosis in Ldlr-/- mice |
| Q36848288 | Leishmania major Self-Limited Infection Increases Blood Cholesterol and Promotes Atherosclerosis Development |
| Q37348110 | Lentiviral transduction of apoAI into hematopoietic progenitor cells and macrophages: applications to cell therapy of atherosclerosis |
| Q33746665 | Leukocyte adhesion molecules in atherogenesis |
| Q34557497 | Lipoprotein size and susceptibility to atherosclerosis--insights from genetically modified mouse models |
| Q44967456 | Liver gene expression associated with diet and lesion development in atherosclerosis-prone mice: induction of components of alternative complement pathway. |
| Q37594100 | Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor α to regulate metabolic hormone FGF21. |
| Q57027887 | Loss of ACAT1 Attenuates Atherosclerosis Aggravated by Loss of NCEH1 in Bone Marrow-Derived Cells |
| Q43865549 | Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice |
| Q33648138 | Low-sodium diet induces atherogenesis regardless of lowering blood pressure in hypertensive hyperlipidemic mice |
| Q34109302 | Loxoprofen Sodium, a Non-Selective NSAID, Reduces Atherosclerosis in Mice by Reducing Inflammation. |
| Q36072647 | Lymphocytes are important in early atherosclerosis |
| Q33844451 | MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. |
| Q46956583 | Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency |
| Q44608571 | Macrophage apolipoprotein A-I expression protects against atherosclerosis in ApoE-deficient mice and up-regulates ABC transporters. |
| Q36709603 | Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity |
| Q28588806 | Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice |
| Q33853087 | Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo |
| Q38296207 | Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice. |
| Q35765799 | Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice |
| Q42180062 | Magnetic Resonance Imaging of Atherosclerosis Using CD81-Targeted Microparticles of Iron Oxide in Mice |
| Q40037679 | Maternal high-fat feeding in pregnancy programs atherosclerotic lesion size in the ApoE*3 Leiden mouse. |
| Q37161229 | Maternal undernutrition programmes atherosclerosis in the ApoE*3-Leiden mouse |
| Q93011588 | Metformin Attenuates Early-Stage Atherosclerosis in Mildly Hyperglycemic Oikawa-Nagao Mice |
| Q36519806 | MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice |
| Q44502393 | Monocyte chemoattractant protein-1 involvement in the alpha-tocopherol-induced reduction of atherosclerotic lesions in apolipoprotein E knockout mice |
| Q30481132 | Mouse models of arteriosclerosis: from arterial injuries to vascular grafts |
| Q38293457 | Mouse models of disturbed HDL metabolism |
| Q74176519 | Myeloid related protein (MRP) 14 expressing monocytes infiltrate atherosclerotic lesions of ApoE null mice |
| Q36005139 | Myeloid-specific Krüppel-like factor 2 inactivation increases macrophage and neutrophil adhesion and promotes atherosclerosis |
| Q33881734 | NMR-based metabolomics of urine for the atherosclerotic mouse model using apolipoprotein-E deficient mice |
| Q44323109 | NOS inhibition accelerates atherogenesis: reversal by exercise |
| Q36747201 | Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice |
| Q39504039 | Natural Biflavonoids Modulate Macrophage-Oxidized LDL Interaction In Vitro and Promote Atheroprotection In Vivo |
| Q38887788 | New indole-thiazolidine attenuates atherosclerosis in LDLr(-/-) mice. |
| Q43658826 | Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis |
| Q44451616 | Nitric oxide-releasing agent, LA419, reduces atherogenesis in apolipoprotein E-deficient mice |
| Q44355109 | No effect of cyclooxygenase inhibition on plaque size in atherosclerosis-prone mice |
| Q43687605 | Non-obese diabetic (NOD) mice exhibit an increased cellular immune response to glycated-LDL but are resistant to high fat diet induced atherosclerosis |
| Q51061720 | Nuclear complex of glyceraldehyde-3-phosphate dehydrogenase and DNA repair enzyme apurinic/apyrimidinic endonuclease I protect smooth muscle cells against oxidant-induced cell death. |
| Q43545481 | Omapatrilat, a dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, prevents fatty streak deposit in apolipoprotein E-deficient mice. |
| Q38876119 | Omics-based approaches to understand mechanosensitive endothelial biology and atherosclerosis |
| Q34053150 | On the mechanism of accumulation of cholestanol in the brain of mice with a disruption of sterol 27-hydroxylase. |
| Q78383751 | Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions |
| Q44627930 | Overexpression of Prdx6 reduces H2O2 but does not prevent diet-induced atherosclerosis in the aortic root |
| Q34794990 | Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice |
| Q73409190 | Overexpression of low density lipoprotein receptor eliminates apolipoprotein B100-containing lipoproteins from circulation and markedly prevents early atherogenesis in apolipoprotein E-deficient mice |
| Q49459817 | PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction |
| Q37606460 | PTEN phosphorylation and nuclear export mediate free fatty acid-induced oxidative stress |
| Q37368611 | Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice |
| Q37406316 | Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis |
| Q34334149 | Pathogen-accelerated atherosclerosis occurs early after exposure and can be prevented via immunization. |
| Q46965143 | Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe(-/-) mice |
| Q36390602 | Piperlongumine inhibits atherosclerotic plaque formation and vascular smooth muscle cell proliferation by suppressing PDGF receptor signaling |
| Q37486124 | Pitfalls in the assessment of murine atherosclerosis |
| Q28591047 | Pla2g12b and Hpn are genes identified by mouse ENU mutagenesis that affect HDL cholesterol |
| Q34656954 | Plasma phospholipid transfer activity is essential for increased atherogenesis in PLTP transgenic mice: a mutation-inactivation study |
| Q36586261 | Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis |
| Q74449529 | Poloxamer 407-induced atherogenesis in the C57BL/6 mouse |
| Q45306054 | Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility |
| Q34264552 | Positive outcomes of oil palm phenolics on degenerative diseases in animal models |
| Q54469402 | Possible role of fibroblast growth factor 21 on atherosclerosis via amelioration of endoplasmic reticulum stress-mediated apoptosis in apoE(-/-) mice. |
| Q39476559 | Prenatal stress enhances severity of atherosclerosis in the adult apolipoprotein E-deficient mouse offspring via inflammatory pathways. |
| Q59387677 | Pro-inflammatory effects of the mushroom Agaricus blazei and its consequences on atherosclerosis development |
| Q34582934 | Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice. |
| Q77340441 | Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study |
| Q44444364 | Protective Effect of the Immunosuppressant Sirolimus Against Aortic Atherosclerosis In Apo E-Deficient Mice |
| Q44639031 | Quantitative Trait Loci Analysis for Plasma HDL-Cholesterol Concentrations and Atherosclerosis Susceptibility Between Inbred Mouse Strains C57BL/6J and 129S1/SvImJ |
| Q40289404 | Quantitative analysis and characterization of atherosclerotic lesions in the murine aortic sinus |
| Q40096484 | Quantitative and qualitative estimation of atherosclerotic plaque burden in vivo at 7T MRI using Gadospin F in comparison to en face preparation evaluated in ApoE KO mice |
| Q46348862 | Quantitative trait locus analysis of susceptibility to diet-induced atherosclerosis in recombinant inbred mice |
| Q41941377 | Reciprocal expression of MRTF-A and myocardin is crucial for pathological vascular remodelling in mice. |
| Q47871314 | Red yeast rice prevents atherosclerosis through regulating inflammatory signaling pathways |
| Q33359505 | Reduced antioxidant capacity and diet-induced atherosclerosis in uncoupling protein-2-deficient mice |
| Q37113551 | Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice |
| Q73091575 | Reduced progression of atherosclerosis in apolipoprotein E-deficient mice with phenylhydrazine-induced anemia |
| Q44167880 | Reduction of blood pressure, plasma cholesterol, and atherosclerosis by elevated endothelial nitric oxide |
| Q33712706 | Relative contributions of age and atherosclerosis to vascular stiffness |
| Q34371163 | Remodeling of the thoracic aorta after bone marrow cell transplantation. |
| Q35757573 | Repetitive Glucose Spikes Accelerate Atherosclerotic Lesion Formation in C57BL/6 Mice. |
| Q33922273 | Requirement of JNK1 for endothelial cell injury in atherogenesis. |
| Q44547302 | Response to sex hormones differs in atherosclerosis-susceptible and -resistant mice. |
| Q43690451 | Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo |
| Q35794774 | Role of Insulin in the Regulation of Proprotein Convertase Subtilisin/Kexin Type 9. |
| Q83347224 | Role of regulatory T cells in atheroprotective effects of granulocyte colony-stimulating factor |
| Q40748004 | S100A8, S100A9 and the S100A8/A9 heterodimer complex specifically bind to human endothelial cells: identification and characterization of ligands for the myeloid-related proteins S100A9 and S100A8/A9 on human dermal microvascular endothelial cell li |
| Q40723319 | Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway |
| Q41932483 | Scavenger Receptor CD36 Directs Nonclassical Monocyte Patrolling Along the Endothelium During Early Atherogenesis |
| Q78004672 | Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice |
| Q98471259 | Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr-/- mice |
| Q35433466 | Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis |
| Q34459166 | Selective macrophage ascorbate deficiency suppresses early atherosclerosis |
| Q59070155 | Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein |
| Q38299150 | Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. |
| Q89054799 | Sexual dimorphism of cardiometabolic dysfunction: Gut microbiome in the play? |
| Q91754407 | Smooth Muscle Cells Contribute the Majority of Foam Cells in ApoE (Apolipoprotein E)-Deficient Mouse Atherosclerosis |
| Q34134537 | Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability |
| Q42063327 | Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model |
| Q37677201 | Soy milk versus simvastatin for preventing atherosclerosis and left ventricle remodeling in LDL receptor knockout mice |
| Q79308118 | Soy protein containing isoflavones favorably influences macrophage lipoprotein metabolism but not the development of atherosclerosis in CETP transgenic mice |
| Q37594563 | Soy protein inhibits inflammation-induced VCAM-1 and inflammatory cytokine induction by inhibiting the NF-κB and AKT signaling pathway in apolipoprotein E-deficient mice |
| Q47697420 | State of the art: atherosclerosis in a limited edition |
| Q35685116 | Structural and ultrastructural evaluation of the aortic wall after transplantation of bone marrow-derived cells (BMCs) in a model for atherosclerosis. |
| Q41009444 | Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts |
| Q37496934 | Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase |
| Q81334397 | Suppressive oligodeoxynucleotides inhibit atherosclerosis in ApoE(-/-) mice through modulation of Th1/Th2 balance |
| Q46067590 | Systems genetics identifies a co-regulated module of liver microRNAs associated with plasma LDL cholesterol in murine diet-induced dyslipidemia |
| Q44314934 | T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice |
| Q38711092 | Tanshinone IIA Attenuates Atherosclerosis in Apolipoprotein E Knockout Mice Infected with Porphyromonas gingivalis |
| Q37613222 | Targeting GGTase-I activates RHOA, increases macrophage reverse cholesterol transport, and reduces atherosclerosis in mice |
| Q37568474 | Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J mice |
| Q33897937 | The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice |
| Q40639637 | The adaptor protein beta-arrestin2 enhances endocytosis of the low density lipoprotein receptor |
| Q44249441 | The atheroprotective effect of 17 beta-estradiol is not altered in P-selectin- or ICAM-1-deficient hypercholesterolemic mice. |
| Q37372718 | The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice |
| Q64098136 | The pro-atherogenic response to disturbed blood flow is increased by a western diet, but not by old age |
| Q36563042 | The role of endothelial mechanosensitive genes in atherosclerosis and omics approaches |
| Q46817321 | The role of macrophage leptin receptor in aortic root lesion formation |
| Q42144013 | Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease |
| Q57784167 | Transcriptome Analysis Reveals Nonfoamy Rather Than Foamy Plaque Macrophages Are Proinflammatory in Atherosclerotic Murine Models |
| Q34218397 | Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet. |
| Q42373717 | Trimethylamine-N-Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3-SOD2-mtROS Signaling Pathway |
| Q41108389 | Ultra-high-resolution 3D imaging of atherosclerosis in mice with synchrotron differential phase contrast: a proof of concept study. |
| Q45884595 | Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation |
| Q33680644 | Using advanced intercross lines for high-resolution mapping of HDL cholesterol quantitative trait loci |
| Q30485641 | Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis |
| Q43281326 | Vasodilating dipeptide Trp-His can prevent atherosclerosis in apo E-deficient mice. |
| Q28278954 | Wnt5a is expressed in murine and human atherosclerotic lesions |
| Q40122954 | Xenogenic macrophage immunization reduces atherosclerosis in apolipoprotein E knockout mice. |
| Q28364478 | p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice |
| Q89761518 | β-hydroxybutyrate Impedes the Progression of Alzheimer's Disease and Atherosclerosis in ApoE-Deficient Mice |
| Q37729585 | β3-Adrenoceptor activation attenuates atherosclerotic plaque formation in ApoE(-/-) mice through lowering blood lipids and glucose |
Search more.